DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Coleman RL, Brady W, McMeekin DS. et al.
A phase II evaluation of nab-paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group (GOG) study.
J Clin Oncol 2010;
28 (15_suppl): 5010
doi:10.1200/jco.2010.28.15_suppl.5010
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.